- Home
- TARS vs ASTH Comparison
TARS vs ASTH Comparison
Compare TARS & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- ASTH
- Stock Information
- Founded
- TARS 2016
- ASTH 1994
- Country
- TARS United States
- ASTH United States
- Employees
- TARS N/A
- ASTH N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- ASTH Professional Services
- Sector
- TARS Health Care
- ASTH Consumer Discretionary
- Exchange
- TARS Nasdaq
- ASTH Nasdaq
- Market Cap
- TARS 1.8B
- ASTH 1.7B
- IPO Year
- TARS 2020
- ASTH N/A
- Fundamental
- Price
- TARS $40.65
- ASTH $24.00
- Analyst Decision
- TARS Strong Buy
- ASTH Strong Buy
- Analyst Count
- TARS 7
- ASTH 8
- Target Price
- TARS $67.14
- ASTH $53.29
- AVG Volume (30 Days)
- TARS 552.3K
- ASTH 220.5K
- Earning Date
- TARS 08-07-2025
- ASTH 08-06-2025
- Dividend Yield
- TARS N/A
- ASTH N/A
- EPS Growth
- TARS N/A
- ASTH N/A
- EPS
- TARS N/A
- ASTH 0.73
- Revenue
- TARS $233,674,000.00
- ASTH $2,250,574,000.00
- Revenue This Year
- TARS $122.94
- ASTH $34.97
- Revenue Next Year
- TARS $44.14
- ASTH $21.52
- P/E Ratio
- TARS N/A
- ASTH $32.84
- Revenue Growth
- TARS 449.03
- ASTH 54.81
- 52 Week Low
- TARS $20.08
- ASTH $23.12
- 52 Week High
- TARS $57.28
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- TARS 40.26
- ASTH 34.33
- Support Level
- TARS $39.25
- ASTH $24.76
- Resistance Level
- TARS $42.01
- ASTH $26.41
- Average True Range (ATR)
- TARS 1.93
- ASTH 0.93
- MACD
- TARS -0.05
- ASTH 0.07
- Stochastic Oscillator
- TARS 22.95
- ASTH 5.06
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.